Evidence map›Paper›PMID 35278075›Full record

ReviewThe Journal of nutrition2022

Tomatoes, Lycopene, and Prostate Cancer: What Have We Learned from Experimental Models?

Nancy E Moran, Jennifer M Thomas-Ahner, Lei Wan, Krystle E Zuniga, John W Erdman, Steven K Clinton

Open access · greenAbstract readReview
In one paragraph

Review in The Journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 1 pooled it
4.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 1 synthesis or guideline pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Correlation between plasma lycopene levels in patients with laryngeal carcinoma and postoperative adverse complications of chemoradiotherapy and nutritional risks.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2024
    Article
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Nancy E MoranUSDA/ARS Children's Nutrition Research Center, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.
Jennifer M Thomas-AhnerThe Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
Lei WanThe Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.ORCID 0000-0002-7771-2474
Krystle E ZunigaDivision of Nutritional Sciences, University of Illinois, Urbana, IL, USA.
John W ErdmanDivision of Nutritional Sciences, University of Illinois, Urbana, IL, USA.
Steven K ClintonThe Ohio State University Comprehensive Cancer Center, The Ohio State University, Columbus, OH, USA.
The Ohio State University · USChildren's Nutrition Research Center at Baylor College of Medicine · USLivestrong Foundation · USThe Ohio State University Wexner Medical Center · USUniversity of Illinois Urbana-Champaign · US

Funding

Tomatoes, Lycopene, and Prostate Carcinogenesis in MiceR01CA125384 · NCI · UNIVERSITY OF ILLINOIS AT URBANA-CHAMPAIGN · PI ERDMAN, JOHN W · 2007 to 2011
$1.4M
NCI NIH HHS R01 CA125384
6 · The paper itself

Abstract

Human epidemiology suggests a protective effect of tomatoes or tomato phytochemicals, such as lycopene, on prostate cancer risk. However, human epidemiology alone cannot reveal causal relations. Laboratory animal models of prostate cancer provide opportunities to investigate hypotheses regarding dietary components in precisely controlled, experimental systems, contributing to our understanding of diet and cancer risk relations. We review the published studies evaluating the impact of tomatoes and/or lycopene in preclinical models of prostate carcinogenesis and tumorigenesis. The feeding of tomatoes or tomato components demonstrates anti-prostate cancer activity in both transplantable xenograft models of tumorigenesis and models of chemically- and genetically-driven carcinogenesis. Feeding pure lycopene shows anticancer activity in most studies, although outcomes vary by model system, suggesting that the impact of pure lycopene can depend on dose, duration, and specific carcinogenic processes represented in different models. Nonetheless, studies with the transgenic adenocarcinoma of the mouse prostate (TRAMP) model of carcinogenesis typically demonstrate similar bioactivity to that of tomato feeding. In general, interventions that commence earlier in carcinogenesis and are sustained tend to be more efficacious. Accumulated data suggest that lycopene is one, but perhaps not the only, anticancer bioactive compound in tomatoes. Although it is clear that tomatoes and lycopene have anti-prostate cancer activity in rodent models, major knowledge gaps remain in understanding dose-response relations and molecular mechanisms of action. Published and future findings from rodent studies can provide guidance for translational scientists to design and execute informative human clinical trials of prostate cancer prevention or in support of therapy.

Indexed as

Anticarcinogenic AgentsProstatic NeoplasmsSolanum lycopersicumAnimalsCarcinogenesisCarotenoidsDisease Models, AnimalHumansLycopeneMaleMiceAnticarcinogenic AgentsCarotenoidsLycopenenutritionpreclinical modelsprostate carcinogenesisprostate metastasistomato

Identifiers

PMID35278075
PMCPMC9178968
OpenAlexW4220919797

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.